T1	Participants 25 118	the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass
T2	Participants 504 515	13 patients
T3	Participants 1793 1837	patients undergoing cardiac surgery with CPB
T4	Participants 292 361	patients undergoing cardiac surgery with cardiopulmonary bypass (CPB)
